Masha Huang

627 total citations
23 papers, 478 citations indexed

About

Masha Huang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Masha Huang has authored 23 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Masha Huang's work include Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (6 papers). Masha Huang is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (6 papers). Masha Huang collaborates with scholars based in China and United States. Masha Huang's co-authors include Zhaoqian Liu, Ji‐Ye Yin, Xi Li, Tao Zhu, Hong‐Hao Zhou, Chenjing Wang, Wei Zhang, Yuanfeng Gao, Pan Xie and Hong‐Hao Zhou and has published in prestigious journals such as The FASEB Journal, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Masha Huang

22 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masha Huang China 12 377 238 89 88 38 23 478
Chengling Zhao China 15 447 1.2× 326 1.4× 85 1.0× 129 1.5× 33 0.9× 20 592
Shuliang Zhao China 13 293 0.8× 146 0.6× 112 1.3× 88 1.0× 41 1.1× 21 469
Wolong Zhou China 12 304 0.8× 157 0.7× 79 0.9× 96 1.1× 38 1.0× 21 427
Qing-Yun Chong Singapore 14 280 0.7× 184 0.8× 109 1.2× 140 1.6× 30 0.8× 16 472
Liyun Luo China 11 428 1.1× 348 1.5× 46 0.5× 80 0.9× 27 0.7× 17 529
Xiangyun Zong China 10 252 0.7× 201 0.8× 77 0.9× 133 1.5× 21 0.6× 35 449
Xu-Chen Cao China 13 340 0.9× 298 1.3× 51 0.6× 116 1.3× 72 1.9× 17 512
Ranran Kong China 14 331 0.9× 189 0.8× 67 0.8× 107 1.2× 27 0.7× 37 445

Countries citing papers authored by Masha Huang

Since Specialization
Citations

This map shows the geographic impact of Masha Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masha Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masha Huang more than expected).

Fields of papers citing papers by Masha Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masha Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masha Huang. The network helps show where Masha Huang may publish in the future.

Co-authorship network of co-authors of Masha Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Masha Huang. A scholar is included among the top collaborators of Masha Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masha Huang. Masha Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Masha, Jingyi Sun, Xin Zhao, et al.. (2025). CircKIAA0182-YBX1 Axis: A Key Driver of Lung Cancer Progression and Chemoresistance. Cancer Letters. 612. 217494–217494. 2 indexed citations
2.
Su, Jun‐Cheng, Jiahui Wang, Weilin Chen, et al.. (2025). Unveiling MAGEA3: a novel predictive biomarker for bevacizumab resistance in colorectal cancer. Cancer Drug Resistance. 8. 22–22.
3.
Han, Xu, et al.. (2024). The Human Milk-derived Peptide Drives Rapid Regulation of Macrophage Inflammation Responses in the Neonatal Intestine. Cellular and Molecular Gastroenterology and Hepatology. 19(2). 101420–101420. 2 indexed citations
4.
Cai, Ying, Yun Li, Yingjie Xu, Wen Yang, & Masha Huang. (2024). TCEB3 initiates ovarian cancer apoptosis by mediating ubiquitination and degradation of MCL‐1. The FASEB Journal. 38(8). e23625–e23625. 2 indexed citations
5.
He, Xiang, Jiahui Zhang, Masha Huang, et al.. (2024). Serum apolipoprotein H determines ferroptosis resistance by modulating cellular lipid composition. Cell Death and Disease. 15(10). 718–718. 3 indexed citations
6.
Yuan, Fuqiang, Masha Huang, Xiao‐Yuan Mao, et al.. (2024). Hsa_circ_0092856 Promoted the Proliferation, Migration, and Invasion of NSCLC Cells by Up-Regulating the Expression of eIF3a. Biomedicines. 12(1). 247–247. 1 indexed citations
7.
Xia, Jia, Yutong Hou, Yingjie Xu, et al.. (2023). An integrated co-expression network analysis reveals novel genetic biomarkers for immune cell infiltration in chronic kidney disease. Frontiers in Immunology. 14. 1129524–1129524. 11 indexed citations
8.
Hou, Yutong, Sihao Lin, Yu Zhang, et al.. (2023). Alleviation of ischemia-reperfusion induced renal injury by chemically modified SOD2 mRNA delivered via lipid nanoparticles. Molecular Therapy — Nucleic Acids. 34. 102067–102067. 13 indexed citations
9.
Li, Yun, Ying Cai, Hua Liu, et al.. (2023). VSTM2L contributes to anoikis resistance and acts as a novel biomarker for metastasis and clinical outcome in ovarian cancer. Biochemical and Biophysical Research Communications. 658. 107–115. 7 indexed citations
10.
Yan, Ran, Wenjing Wang, Wen Yang, Masha Huang, & Wei Xu. (2023). Mitochondria-Related Candidate Genes and Diagnostic Model to Predict Late-Onset Alzheimer’s Disease and Mild Cognitive Impairment. Journal of Alzheimer s Disease. 99(s2). S299–S315. 10 indexed citations
11.
Zhang, Jingjing, Yun Li, Hua Liu, et al.. (2022). Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis. Journal of Experimental & Clinical Cancer Research. 41(1). 24–24. 40 indexed citations
12.
Chen, Yixin, Liming Tan, Masha Huang, et al.. (2021). Response prediction biomarkers and drug combinations of PARP inhibitors in prostate cancer. Acta Pharmacologica Sinica. 42(12). 1970–1980. 6 indexed citations
13.
Xie, Pan, Fuqiang Yuan, Masha Huang, et al.. (2021). DCBLD2 Affects the Development of Colorectal Cancer via EMT and Angiogenesis and Modulates 5-FU Drug Resistance. Frontiers in Cell and Developmental Biology. 9. 669285–669285. 24 indexed citations
14.
Xiao, Zhiyu, et al.. (2020). 68P Analysis of DNA damage repair (DDR) pathway genes in biliary tract cancer and correlation with immunogenic biomarker. Annals of Oncology. 31. S267–S267. 1 indexed citations
15.
Huang, Masha, Fuqiang Yuan, Yang Gao, et al.. (2019). Circular RNA screening from EIF3a in lung cancer. Cancer Medicine. 8(9). 4159–4168. 22 indexed citations
16.
Huang, Masha, Junyan Liu, Xiaobo Xia, et al.. (2019). Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway. Frontiers in Oncology. 9. 508–508. 78 indexed citations
17.
Liu, Shaobo, Ji‐Ye Yin, Wei Zhuo, et al.. (2019). The Fibroblast TIAM2 Promotes Lung Cancer Cell Invasion and Metastasis. Journal of Cancer. 10(8). 1879–1889. 15 indexed citations
18.
Zhu, Tao, Pan Xie, Yuanfeng Gao, et al.. (2018). Nucleolar and spindle‐associated protein 1 is a tumor grade correlated prognosis marker for glioma patients. CNS Neuroscience & Therapeutics. 24(3). 178–186. 28 indexed citations
19.
Huang, Masha, Tao Zhu, Ling Li, et al.. (2017). LncRNAs and CircRNAs from the same gene: Masterpieces of RNA splicing. Cancer Letters. 415. 49–57. 30 indexed citations
20.
Li, Ling, Tao Zhu, Yuanfeng Gao, et al.. (2016). Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 17(6). 839–839. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026